$3.19 Billion is the total value of Perceptive Advisors's 111 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 34.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $455,940,000 | -3.8% | 45,000,000 | 0.0% | 14.28% | +50.4% | ||
| FOLD | Sell | AMICUS THERAPEUTICS INC | $288,858,000 | +10.7% | 26,895,532 | -2.4% | 9.05% | +73.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $192,453,000 | -1.7% | 2,866,863 | +20.4% | 6.03% | +53.7% |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $134,493,000 | -24.5% | 5,086,727 | 0.0% | 4.21% | +18.1% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $130,562,000 | -35.7% | 11,826,299 | -3.1% | 4.09% | +0.5% |
| Buy | LIANBIOsponsored ads | $122,170,000 | -41.5% | 56,560,211 | +0.4% | 3.83% | -8.6% | |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $99,237,000 | -12.4% | 5,321,032 | +3.1% | 3.11% | +36.9% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $96,331,000 | -28.6% | 3,015,054 | -22.5% | 3.02% | +11.7% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $95,217,000 | -62.7% | 3,867,446 | -14.6% | 2.98% | -41.7% |
| Buy | AMYLYX PHARMACEUTICALS INC | $68,188,000 | +260.0% | 3,540,408 | +140.2% | 2.14% | +463.6% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $64,568,000 | -12.4% | 2,122,535 | -12.0% | 2.02% | +36.9% |
| MGTX | Buy | MEIRAGTX HLDGS PLC | $52,712,000 | -45.2% | 6,963,277 | +0.2% | 1.65% | -14.3% |
| LYRA | Buy | LYRA THERAPEUTICS INC | $51,679,000 | +298.9% | 9,146,730 | +183.8% | 1.62% | +522.7% |
| BLU | Sell | BELLUS HEALTH INC NEW | $51,136,000 | -8.7% | 5,534,169 | -32.0% | 1.60% | +42.9% |
| RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $47,490,000 | -48.5% | 1,682,242 | -31.1% | 1.49% | -19.4% |
| ALBO | ALBIREO PHARMA INC | $46,872,000 | -33.4% | 2,360,139 | 0.0% | 1.47% | +4.1% | |
| CINCOR PHARMA INC | $43,692,000 | +7.4% | 2,319,117 | 0.0% | 1.37% | +67.9% | ||
| VBIV | VBI VACCINES INC CDA | $42,312,000 | -51.3% | 52,335,002 | 0.0% | 1.32% | -23.9% | |
| SGEN | New | SEAGEN INC | $39,635,000 | – | 224,000 | +100.0% | 1.24% | – |
| VERU | Sell | VERU INC | $39,550,000 | +87.7% | 3,500,000 | -19.8% | 1.24% | +193.6% |
| ALDX | ALDEYRA THERAPEUTICS INC | $39,516,000 | -10.2% | 9,903,879 | 0.0% | 1.24% | +40.4% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $38,786,000 | +4.6% | 397,888 | +0.6% | 1.22% | +63.5% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $34,927,000 | -43.3% | 1,913,791 | -31.6% | 1.09% | -11.3% |
| RLAY | RELAY THERAPEUTICS INC | $32,546,000 | -44.0% | 1,943,097 | 0.0% | 1.02% | -12.5% | |
| LLY | New | LILLY ELI & CO | $32,423,000 | – | 100,000 | +100.0% | 1.02% | – |
| COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $29,484,000 | -33.9% | 4,500,000 | 0.0% | 0.92% | +3.4% | ||
| COGT | Sell | COGENT BIOSCIENCES INC | $27,863,000 | +16.7% | 3,088,972 | -3.1% | 0.87% | +82.6% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $26,393,000 | -56.5% | 3,645,471 | -22.4% | 0.83% | -31.9% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $26,306,000 | -3.7% | 367,501 | +32.1% | 0.82% | +50.6% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $25,231,000 | -14.2% | 172,991 | -3.9% | 0.79% | +34.1% |
| Sell | PROCEPT BIOROBOTICS CORP | $24,508,000 | -52.9% | 749,700 | -49.6% | 0.77% | -26.4% | |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | $24,508,000 | -38.0% | 9,111,151 | 0.0% | 0.77% | -3.0% | |
| ADMA | Sell | ADMA BIOLOGICS INC | $22,812,000 | +4.5% | 11,521,102 | -3.5% | 0.71% | +63.4% |
| Sell | NUVALENT INC | $22,442,000 | -7.8% | 1,655,007 | -5.5% | 0.70% | +44.4% | |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $22,065,000 | -27.3% | 405,759 | -9.9% | 0.69% | +13.7% |
| ZYME | Sell | ZYMEWORKS INC | $21,902,000 | -37.2% | 4,132,534 | -22.4% | 0.69% | -1.9% |
| IMTX | IMMATICS N.V | $21,775,000 | +9.0% | 2,500,000 | 0.0% | 0.68% | +70.5% | |
| INBX | Buy | INHIBRX INC | $21,731,000 | -45.2% | 1,914,592 | +7.5% | 0.68% | -14.3% |
| New | ARCELLX INC | $20,647,000 | – | 1,141,990 | +100.0% | 0.65% | – | |
| ISEE | Sell | IVERIC BIO INC | $20,086,000 | -77.2% | 2,087,956 | -60.0% | 0.63% | -64.3% |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $20,084,000 | – | 411,804 | +100.0% | 0.63% | – |
| TARS | TARSUS PHARMACEUTICALS INC | $18,927,000 | -13.2% | 1,296,416 | 0.0% | 0.59% | +35.7% | |
| CRY | Buy | ARTIVION INC | $17,553,000 | +33.3% | 929,705 | +51.0% | 0.55% | +108.3% |
| Sell | DICE THERAPEUTICS INC | $16,326,000 | -43.7% | 1,051,904 | -30.6% | 0.51% | -12.0% | |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $16,056,000 | -39.7% | 1,166,883 | -30.5% | 0.50% | -5.6% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $15,409,000 | -60.5% | 1,697,033 | -55.8% | 0.48% | -38.2% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $14,917,000 | – | 180,000 | +100.0% | 0.47% | – |
| OM | Sell | OUTSET MED INC | $14,841,000 | -82.6% | 998,727 | -47.0% | 0.46% | -72.9% |
| ATHA | Buy | ATHIRA PHARMA INC | $14,632,000 | -68.4% | 4,797,278 | +40.0% | 0.46% | -50.5% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $14,529,000 | -80.7% | 321,300 | -78.3% | 0.46% | -69.8% |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $13,813,000 | -71.0% | 570,084 | -69.1% | 0.43% | -54.6% |
| RAIN | RAIN THERAPEUTICS INC | $13,809,000 | +9.7% | 2,483,619 | 0.0% | 0.43% | +71.8% | |
| TMCI | Sell | TREACE MED CONCEPTS INC | $13,497,000 | -26.5% | 941,192 | -3.1% | 0.42% | +14.9% |
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $13,509,000 | -41.4% | 3,536,274 | -3.3% | 0.42% | -8.4% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $12,214,000 | -19.6% | 2,915,146 | -4.2% | 0.38% | +26.0% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $11,244,000 | -57.3% | 971,832 | -31.7% | 0.35% | -33.2% |
| CCXI | Sell | CHEMOCENTRYX INC | $10,945,000 | -73.6% | 441,680 | -73.3% | 0.34% | -58.7% |
| CMAX | Sell | CAREMAX INC | $10,890,000 | -54.3% | 3,000,000 | -5.9% | 0.34% | -28.5% |
| LABP | LANDOS BIOPHARMA INC | $10,823,000 | -50.7% | 14,869,915 | 0.0% | 0.34% | -22.8% | |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $9,953,000 | +80.4% | 556,047 | 0.0% | 0.31% | +183.6% | |
| VRCA | Buy | VERRICA PHARMACEUTICALS INC | $9,675,000 | -67.0% | 5,038,983 | +39.6% | 0.30% | -48.4% |
| LPTX | LEAP THERAPEUTICS INC | $9,144,000 | -34.3% | 7,951,448 | 0.0% | 0.29% | +2.5% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $9,054,000 | +24.9% | 2,150,641 | 0.0% | 0.28% | +95.9% | |
| ISOPLEXIS CORP | $8,846,000 | -37.0% | 4,095,498 | 0.0% | 0.28% | -1.4% | ||
| KRON | KRONOS BIO INC | $8,812,000 | -49.7% | 2,421,142 | 0.0% | 0.28% | -21.4% | |
| New | HILLEVAX INC | $8,360,000 | – | 764,907 | +100.0% | 0.26% | – | |
| SLDB | SOLID BIOSCIENCES INC | $8,257,000 | -48.7% | 13,412,552 | 0.0% | 0.26% | -19.6% | |
| PRVA | Buy | PRIVIA HEALTH GROUP INC | $7,962,000 | +39.6% | 273,423 | +28.1% | 0.25% | +118.4% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $7,912,000 | +195.0% | 572,514 | +316.3% | 0.25% | +359.3% |
| MORF | Sell | MORPHIC HLDG INC | $7,881,000 | -74.4% | 363,197 | -52.7% | 0.25% | -60.0% |
| XBI | New | SPDR SER TRput | $7,427,000 | – | 100,000 | +100.0% | 0.23% | – |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $7,314,000 | -23.1% | 1,073,995 | -10.1% | 0.23% | +19.9% |
| SOMALOGIC INC | $6,780,000 | -43.6% | 1,500,000 | 0.0% | 0.21% | -12.0% | ||
| HCAT | Sell | HEALTH CATALYST INC | $6,740,000 | -47.7% | 465,162 | -5.8% | 0.21% | -18.2% |
| Buy | SEMA4 HOLDINGS CORP | $6,300,000 | -17.9% | 5,000,000 | +100.0% | 0.20% | +27.9% | |
| Sell | ICOSAVAX INC | $5,976,000 | -38.4% | 1,042,850 | -24.4% | 0.19% | -3.6% | |
| CCCC | Sell | C4 THERAPEUTICS INC | $5,777,000 | -88.6% | 766,231 | -63.2% | 0.18% | -82.1% |
| NUVB | NUVATION BIO INC | $5,733,000 | -38.4% | 1,769,701 | 0.0% | 0.18% | -3.2% | |
| ATNX | ATHENEX INC | $5,540,000 | -50.6% | 13,532,467 | 0.0% | 0.17% | -22.7% | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $4,764,000 | -27.9% | 341,239 | -11.0% | 0.15% | +12.9% |
| NBTX | NANOBIOTIXsponsored ads | $4,027,000 | -48.9% | 1,059,800 | 0.0% | 0.13% | -20.3% | |
| QTNT | QUOTIENT LTD | $3,888,000 | -80.0% | 16,200,818 | 0.0% | 0.12% | -68.6% | |
| ASTRIA THERAPEUTICS INC | $3,843,000 | -55.3% | 1,281,197 | 0.0% | 0.12% | -30.2% | ||
| PYXIS ONCOLOGY INC | $3,639,000 | -41.1% | 1,528,812 | 0.0% | 0.11% | -8.1% | ||
| MGNX | Sell | MACROGENICS INC | $3,620,000 | -73.7% | 1,227,202 | -21.3% | 0.11% | -58.9% |
| TYRA BIOSCIENCES INC | $3,535,000 | -33.2% | 494,403 | 0.0% | 0.11% | +4.7% | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | $3,210,000 | -39.7% | 1,500,000 | 0.0% | 0.10% | -5.6% | |
| YMAB | New | Y-MABS THERAPEUTICS INC | $3,208,000 | – | 212,018 | +100.0% | 0.10% | – |
| SCIENCE 37 HOLDINGS INC | $3,015,000 | -62.4% | 1,500,000 | 0.0% | 0.09% | -41.6% | ||
| ENVVENO MEDICAL CORPORATION | $2,954,000 | -40.7% | 781,615 | 0.0% | 0.09% | -7.0% | ||
| Sell | ABSCI CORPORATION | $2,969,000 | -70.4% | 894,346 | -24.9% | 0.09% | -53.7% | |
| SAVA | New | CASSAVA SCIENCES INCput | $2,812,000 | – | 100,000 | +100.0% | 0.09% | – |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $2,621,000 | -72.5% | 1,052,445 | -14.2% | 0.08% | -57.1% |
| Sell | HYPERFINE INC | $2,530,000 | -52.4% | 1,134,388 | -24.4% | 0.08% | -25.5% | |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $2,390,000 | +2.4% | 508,532 | -14.8% | 0.08% | +59.6% |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $2,304,000 | -43.6% | 121,350 | -19.8% | 0.07% | -12.2% |
| DARIOHEALTH CORP | $2,013,000 | +5.1% | 327,869 | 0.0% | 0.06% | +65.8% | ||
| FULC | FULCRUM THERAPEUTICS INC | $1,441,000 | -79.3% | 294,118 | 0.0% | 0.04% | -67.6% | |
| Sell | PEAR THERAPEUTICS INC | $1,386,000 | -70.4% | 900,548 | -2.8% | 0.04% | -54.3% | |
| RACE | FERRARI N V | $1,138,000 | -15.8% | 6,200 | 0.0% | 0.04% | +33.3% | |
| Sell | SONENDO INC | $1,115,000 | -58.4% | 648,505 | -3.0% | 0.04% | -35.2% | |
| ZY | ZYMERGEN INC | $1,086,000 | -57.5% | 883,332 | 0.0% | 0.03% | -33.3% | |
| TARA | Sell | PROTARA THERAPEUTICS INC | $850,000 | -56.6% | 290,051 | -24.4% | 0.03% | -30.8% |
| New | AGILE THERAPEUTICS INC | $620,000 | – | 532,361 | +100.0% | 0.02% | – | |
| MOTS | MOTUS GI HLDGS INC | $507,000 | -21.8% | 1,800,542 | 0.0% | 0.02% | +23.1% | |
| PRVB | Sell | PROVENTION BIO INC | $443,000 | -92.4% | 110,728 | -86.0% | 0.01% | -87.9% |
| EQRX INC*w exp 12/17/202 | $203,000 | -6.9% | 250,000 | 0.0% | 0.01% | +50.0% | ||
| New | NEPTUNE WELLNESS SOLUTIONS I | $81,000 | – | 57,142 | +100.0% | 0.00% | – | |
| SURROZEN INC*w exp 08/01/203 | $32,000 | -23.8% | 166,666 | 0.0% | 0.00% | 0.0% | ||
| Sell | SURROZEN INC | $18,000 | -92.3% | 6,017 | -92.3% | 0.00% | -80.0% | |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $43,000 | -62.3% | 60,000 | 0.0% | 0.00% | -50.0% | |
| BFLYWS | Exit | BUTTERFLY NETWORK INC*w exp 02/12/202 | $0 | – | -233,333 | -100.0% | -0.01% | – |
| Exit | MINERVA SURGICAL INC | $0 | – | -50,268 | -100.0% | -0.01% | – | |
| Exit | SOMALOGIC INC*w exp 08/31/202 | $0 | – | -110,000 | -100.0% | -0.01% | – | |
| NEPT | Exit | NEPTUNE WELLNESS SOLUTIONS I | $0 | – | -2,000,000 | -100.0% | -0.01% | – |
| Exit | ROCKLEY PHOTONICS HOLDINGS L*w exp 08/11/202 | $0 | – | -500,000 | -100.0% | -0.01% | – | |
| Exit | RAPID MICRO BIOSYSTEMS INC | $0 | – | -190,745 | -100.0% | -0.03% | – | |
| ONCR | Exit | ONCORUS INC | $0 | – | -752,241 | -100.0% | -0.03% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -44,475 | -100.0% | -0.03% | – |
| GRPH | Exit | GRAPHITE BIO INC | $0 | – | -325,854 | -100.0% | -0.03% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -65,144 | -100.0% | -0.05% | – |
| NARI | Exit | INARI MED INC | $0 | – | -30,000 | -100.0% | -0.05% | – |
| Exit | IMMUNEERING CORP | $0 | – | -681,051 | -100.0% | -0.09% | – | |
| HSAQ | Exit | HEALTH SCIENCES ACQ CORP 2 | $0 | – | -450,000 | -100.0% | -0.09% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -554,585 | -100.0% | -0.09% | – |
| Exit | SIGHT SCIENCES INC | $0 | – | -390,000 | -100.0% | -0.09% | – | |
| Exit | DA32 LIFE SCNCE TEC ACQSTN C | $0 | – | -500,000 | -100.0% | -0.10% | – | |
| MRUS | Exit | MERUS N V | $0 | – | -209,046 | -100.0% | -0.11% | – |
| ACCD | Exit | ACCOLADE INC | $0 | – | -330,682 | -100.0% | -0.12% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -284,853 | -100.0% | -0.14% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -250,000 | -100.0% | -0.16% | – |
| RACB | Exit | RESEARCH ALLIANCE CORP II | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| SMIHU | Exit | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| Exit | CUE HEALTH INC | $0 | – | -1,580,607 | -100.0% | -0.20% | – | |
| Exit | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $0 | – | -1,000,000 | -100.0% | -0.22% | – | |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -405,000 | -100.0% | -0.26% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -537,779 | -100.0% | -0.27% | – |
| AXNX | Exit | AXONICS INC | $0 | – | -341,211 | -100.0% | -0.43% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -616,141 | -100.0% | -0.45% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -501,509 | -100.0% | -0.46% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -143,591 | -100.0% | -0.64% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -477,037 | -100.0% | -0.69% | – |
| Exit | COLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1 | $0 | – | -9,500,000 | -100.0% | -1.79% | – | |
| HZNP | Exit | HORIZON THERAPEUTICS PLC | $0 | – | -1,357,903 | -100.0% | -2.86% | – |
| AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -21,294,485 | -100.0% | -3.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.